A carregar...

A Randomized, Double-Blind Phase I/IIa Study of Intranasal Glutathione in Parkinson’s Disease

BACKGROUND: Depletion of reduced glutathione is associated with Parkinson’s disease (PD) and glutathione augmentation has been proposed as a disease-modifying strategy. OBJECTIVES: The purpose of this study was to determine the safety and tolerability of intranasal reduced glutathione in individuals...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mov Disord
Main Authors: Mischley, Laurie K, Leverenz, James B, Lau, Richard C, Polissar, Nayak L, Neradilek, Moni B, Samii, Ali, Standish, Leanna J
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4609266/
https://ncbi.nlm.nih.gov/pubmed/26230671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.26351
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!